Sirard Cynthia bought CMPX
January 2, 2026 · Form 4 insider transaction
Sirard Cynthia bought 1,000,000 shares of Compass Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000,000
Price
$0.00
Total value
N/A
InsiderSirard Cynthia
Role—
SecuritySTOCK OPTION (RIGHT TO BUY)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after1,000,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted pursuant to the Compass Therapeutics, Inc. 2025 Inducement Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4).; The options will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 2, 2027, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.